- Home
- INCR vs PYXS Comparison
INCR vs PYXS Comparison
Compare INCR & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- PYXS
- Stock Information
- Founded
- INCR 1994
- PYXS 2018
- Country
- INCR Israel
- PYXS United States
- Employees
- INCR N/A
- PYXS N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- INCR Health Care
- PYXS Health Care
- Exchange
- INCR Nasdaq
- PYXS Nasdaq
- Market Cap
- INCR 86.1M
- PYXS 79.4M
- IPO Year
- INCR N/A
- PYXS 2021
- Fundamental
- Price
- INCR $1.47
- PYXS $3.51
- Analyst Decision
- INCR
- PYXS Strong Buy
- Analyst Count
- INCR 0
- PYXS 5
- Target Price
- INCR N/A
- PYXS $7.75
- AVG Volume (30 Days)
- INCR 135.0K
- PYXS 843.7K
- Earning Date
- INCR 10-08-2025
- PYXS 11-11-2025
- Dividend Yield
- INCR N/A
- PYXS N/A
- EPS Growth
- INCR N/A
- PYXS N/A
- EPS
- INCR N/A
- PYXS N/A
- Revenue
- INCR $72,158,312.00
- PYXS $2,820,000.00
- Revenue This Year
- INCR $69.54
- PYXS N/A
- Revenue Next Year
- INCR $41.75
- PYXS N/A
- P/E Ratio
- INCR N/A
- PYXS N/A
- Revenue Growth
- INCR N/A
- PYXS N/A
- 52 Week Low
- INCR $1.17
- PYXS $0.83
- 52 Week High
- INCR $1.82
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- INCR 39.94
- PYXS 65.17
- Support Level
- INCR $1.55
- PYXS $3.26
- Resistance Level
- INCR $1.65
- PYXS $3.75
- Average True Range (ATR)
- INCR 0.08
- PYXS 0.39
- MACD
- INCR -0.01
- PYXS 0.02
- Stochastic Oscillator
- INCR 19.23
- PYXS 77.20
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.